Skip to main content
Representatives from The University of Toledo and the U.S. Department of Energy’s Oak Ridge National Laboratory (ORNL) in Tennessee are teaming up to conduct collaborative automotive materials research.” Credit: University of Toledo

ORNL and The University of Toledo have entered into a memorandum of understanding for collaborative research.

Isabelle Snyder standing in front of screen dislaying national map of US power grids

Isabelle Snyder calls faults as she sees them, whether it’s modeling operations for the nation’s power grid or officiating at the US Open Tennis Championships.

early prototype of the optical array developed by Oak Ridge National Laboratory.

IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.

In ORNL’s Low Activation Materials Development and Analysis Laboratory, Field makes use of a transmission electron microscope to examine a sample made with a focused ion beam. He investigates the defects produced in a FeCrAl alloy bombarded with neutrons in HFIR. Credit: Carlos Jones/Oak Ridge National Laboratory, U.S. Dept. of Energy

Kevin Field at the Department of Energy’s Oak Ridge National Laboratory synthesizes and scrutinizes materials for nuclear power systems that must perform safely and efficiently over decades of irradiation.

Using as much as 50 percent lignin by weight, a new composite material created at ORNL is well suited for use in 3D printing.

Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.

Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.

The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.